Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: IEEE Trans Med Imaging. 2021 Jun 1;40(6):1687–1701. doi: 10.1109/TMI.2021.3064464

Table I.

Number of dataset samples, ROIs, and pixels

Tissue subtype Samples with ROI n Total pixels
Background 2–5, 7, 9–12, 15, 16, 19–21, 23–25, 27, 29, 30, 31–33, 36, 39, 41, 42, 46, 49, 51–53, 55, 56, 57, 59, 60, 63, 64, 67 40 10,693,158
Adipose Tissue 2–5, 8, 9, 11, 12, 14, 16, 17, 22, 26, 28, 30, 34, 37, 39–42, 44, 45, 47–54, 58–60, 63, 64, 67, 69, 70 39 158,070
Connective Tissue 6, 8, 12, 13, 22, 23, 33, 35, 40, 43, 47–50, 52, 53, 55, 58, 60, 63, 64, 65 22 89,470
Myofibroblastic 38 1 11,522
Benign Phyllodes 57 1 19,201
Normal Treated 20 1 20,740
Fibroadenoma 1, 19, 27, 32 4 45,350
Fibrocystic Disease 4, 5, 7, 9, 11, 32, 36 7 61,907
IDC (Low Grade) 12, 17, 28, 40, 47, 50, 51, 54, 61, 65, 68 11 21,137
IDC (Interm. Grade) 6, 8, 13, 29, 30, 33, 35, 36, 37, 41, 42, 53, 58, 63, 66, 67, 70 17 44,219
IDC (High Grade) 5, 16, 23, 24, 25, 39, 46, 56, 59, 64 10 70,520
ILC 2, 4, 21, 22, 26, 45, 48, 49, 52, 55 10 53,612
DCIS 3, 18, 31, 34, 37, 44, 62 7 26,119
Mucinous 10, 14, 43, 60 4 26,348
Tubular 11, 69 2 3,347
Metaplastic 15 1 18,955
Total non-background 70 137 670,517